Genmab A (GMAB) Profit After Tax: 2018-2020
Historic Profit After Tax for Genmab A (GMAB) over the last 3 years, with Dec 2020 value amounting to $552.7 million.
- Genmab A's Profit After Tax rose 368.57% to $130.14 in Q2 2021 from the same period last year, while for Jun 2021 it was $275.33, marking a year-over-year decrease of 100.00%. This contributed to the annual value of $552.7 million for FY2020, which is 145.38% up from last year.
- Genmab A's Profit After Tax amounted to $552.7 million in FY2020, which was up 145.38% from $225.3 million recorded in FY2019.
- Genmab A's 5-year Profit After Tax high stood at $552.7 million for FY2020, and its period low was $162.7 million during FY2018.
- Its 3-year average for Profit After Tax is $313.6 million, with a median of $225.3 million in 2019.
- Data for Genmab A's Profit After Tax shows a peak YoY soared of 145.38% (in 2020) over the last 5 years.
- Genmab A's Profit After Tax (Yearly) stood at $162.7 million in 2018, then soared by 38.41% to $225.3 million in 2019, then skyrocketed by 145.38% to $552.7 million in 2020.